Inhibition of replication of drug-resistant HIV type 1 isolates by polypurine tract-specific oligodeoxynucleotide TFO A

AIDS Research and Human Retroviruses

Volumn 14, Issue 11, 1998, Pages 999-1005

  Jendis, Jörg ^a   Strack, Bettina ^a   Moelling, Karin ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; ANTIRETROVIRUS AGENT; DEOXYCYTIDINE; DIDANOSINE; NEVIRAPINE; OLIGODEOXYNUCLEOTIDE; PURINE; RNA DIRECTED DNA POLYMERASE; TRIPLE HELIX FORMING OLIGONUCLEOTIDE; UNCLASSIFIED DRUG; ZIDOVUDINE;

ARTICLE; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS CORE; VIRUS GENE; VIRUS ISOLATION; VIRUS MUTANT; VIRUS REPLICATION; VIRUS RESISTANCE; VIRUS STRAIN;

EID: 0032551544     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1998.14.999     Document Type: Article

References (29)

1. Hansen J, Schulze T, Mellert W, and Moelling K: Identification and characterization of HIV-specific RNase H by monoclonal antibody. EMBO J 1988;7:239-243.
2. Wöhrl BM and Moelling K: Interaction of HIV-1 RNase H with polypurine tract containing RNA-DNA hybrids. Biochemistry 1990;29:10141-10147.
3. Moelling K, Bolognesi DP, Bauer H, Buesen W, Plassmann H, and Hausen P: Association of viral reverse transcriptase with an enzyme degrading RNA moiety of RNA-DNA hybrids. Nature (London) 1971;234:240-243.
4. Popovic M, Sarngadharan MG, Read E, and Gallo RC: Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 1984;224:497-500.
5. Volkmann S, Dannull J, and Moelling K: The polypurine tract, PPT, of HIV as target for antisense and triple-helix-forming oligonucleotides. Biochimie 1993;75:71-78.
6. Volkmann S, Jendis J, Frauendorf A, and Mölling K: Inhibition of HIV-1 reverse transcription by triple-helix forming oligonucleotides with viral RNA. Nucleic Acids Res 1995;23:1204-1212.
7. Francois JC and Helene C: Recognition and cleavage of single-stranded DNA containing hairpin structures by oligonucleotides forming both Watson-Crick and Hoogsteen hydrogen bonds. Biochemistry 1995;34:65-72.
8. Jendis J, Strack B, Volkmann S, Böni J, and Mölling K: Inhibition of replication of fresh HIV-1 patient isolates by a PPT-specific self-complementary oligodeoxynucleotide. AIDS Res Hum Retroviruses 1996;12:1161-1168.
9. Gao Q, Gu Z, Parniak MA, Li X, and Wainberg MA: In vitro selection of variants of the human immunodeficiency virus type 1 resistant to 3′-azido-3′-deoxythymidine and 2′,3′-dideoxyinosine. J Virol 1992;66:12-19.
10. Schinazi RF, Lloyd RM, Nguyen MH, Cannon DL, McMillan A, Ilksoy N, Chu CK, Liotta DC, Bazmi HZ, and Mellors JW: Characterization of human immunodeficiency viruses resistant to oxathiolane cytosine nucleosides. Antimicrob Agents Chemother 1993;37:875-881.
11. Larder BA and Kemp SD: Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT). Science 1989;246:1155-1158.
12. Boucher CAB, O'Sullivan E, Mulder JW, Ramautarsing C, Kellam P, Darby G, Lange JMA, Goudsmit J, and Larder BA: Ordered appearance of zidovudine resistance mutation during treatment of 18 human immunodeficiency virus-positive subjects. J Infect Dis 1992;165:105-110.
13. Larder BA, Coates KE, and Kemp SD: Zidovudine-resistant human immunodeficiency virus selected by passage in cell culture. J Virol 1991;65:5232-5236.
14. Salahuddin SZ, Markham PD, Wong-Staal F, Franchini G, Kalyanaraman VS, and Gallo RC: Restricted expression of human T cell leukemia-lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes. Virology 1983;129:51-64.
15. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, and Markowitz M: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature (London) 1995;373:123-126.
16. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoefer S, Nowak MA, Hahn BH, Saag MS, and Shaw GM: Viral dynamics in human immunodeficiency virus type 1 infection. Nature (London) 1995;373:117-122.
17. Krowka JF, Gesner ML, Ascher MS, and Sheppard HW: Lack of associations of chemotactic cytokines with viral burden, disease progression, or lymphocyte subsets in HIV-infected individuals. Clin Immunol Immunopathol 1997;85:21-27.
18. Olivas WM and Maher LJ: Competitive triplex/quadruplex equilibria involving guanine-rich oligonucleotides. Biochemistry 1995;34:278-284.
19. Williamson JR, Raghuraman MK, and Cech TR: Monovalent cation-induced structure of telomeric DNA: The G-quartet model. Cell 1989;59:871-880.
20. Smith M, Salomon H, and Wainberg MA: Development and significance of nucleoside drag resistance in infection caused by the human immunodeficiency virus type 1. Clin Invest Med 1994;17: 226-243.
21. Tantillo C, Ding J, Jacobo-Molina A, Nanni RO, Boyer PL, Hughes SH, Pauwels R, Andries K, Janssen PAJ, and Arnold E: Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. Mol Biol 1994;243:369-387.
22. Richman DD, Shih CK, Lowy I, Rose J, Prodanovich P, Goff S, and Griffin J: Human immunodeficiency virus type 1 mutants resistant to non-nucleoside inhibitors of reverse transcriptase arise in tissue culture. Proc Natl Acad Sci USA 1991;88:11241-11245.
23. Kohlstaedt LA, Wang J, Friedman JM, Rice PA, and Steitz TA: Crystal structure at 3.5 Å resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science 1992;256:1783-1790.
24. Jacobo-Molina A, Ding J, Nanni RG, Clark AD, Lu X, Tantillo C, Williams RL, Kamer G, Ferris AL, Clark P, Hizi A, Hughes SH, and Arnold E: Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 Å resolution shows bent DNA. Proc Natl Acad Sci USA 1993;90:6320-6324.
25. Boyer PL, Currens MJ, McMahon JB, Boyd MR, and Huges SH: Analysis of non-nucleoside drug-resistant variants of human immunodeficiency virus type 1 reverse transcriptase. J Virol 1993;67: 2412-2420.
26. Oyama F, Kikuchi R, Crouch RJ, and Uchida T: Intrinsic properties of reverse transcriptase in reverse transcription. Associated RNase H is essentially regarded as an endonuclease. J Biol Chem 1989;264:18808-18817.
27. Volkmann S, Wöhrl BM, Tisdale M, and Moelling K: Enzymatic analysis of two HIV-1 reverse transcriptase mutants with mutations in carboxyl-terminal amino acid residues conserved among retroviral ribonucleases H. J Biol Chem 1993;268:2674-2683.
28. Giovannangeli C, Diviacco S, Labrousse V, Gryaznov S, Charneau P, and Helene C: Accessibility of nuclear DNA to triplex-forming oligonucleotides: The integrated HIV-1 provirus as a target. Proc Natl Acad Sci USA 1997;94:79-84.
29. Cooney M, Czernuszewicz G, Postel EH, Hint SJ, and Hogan ME: Site-specific oligonucleotide binding represses transcription of the human c-myc gene in vitro. Science 1988;241:456-459.